Early Access

10-QPeriod: Q2 FY2019

SYNOPSYS INC Quarterly Report for Q2 Ended Apr 30, 2019

Filed May 24, 2019For Securities:SNPS

Summary

Synopsys Inc. reported its financial results for the quarter and six months ended April 30, 2019. For the second quarter of fiscal year 2019, total revenue increased by 8% year-over-year to $836.2 million. This growth was driven by strong performance in both the Semiconductor & System Design segment and the Software Integrity segment, with the latter showing a significant 23% revenue increase. Despite revenue growth, operating income saw a slight decrease of 9% to $115.5 million, attributed to increased operating expenses, including a rise in restructuring charges and R&D investments to support future growth. The adoption of ASC 606, the new revenue recognition standard, had a noticeable impact, particularly on upfront revenue recognition, leading to a decrease in reported net income for the quarter compared to what would have been reported under the previous standard. The company maintained a strong balance sheet, with total assets of $6.19 billion and a significant cash and cash equivalents balance of $631.2 million. Management expressed confidence in the company's liquidity and ability to meet its obligations, supported by operational cash flow and available credit facilities.

Financial Statements
Beta
Revenue$836.24M
Cost of Revenue$190.68M
Gross Profit$645.56M
R&D Expenses$290.30M
Operating Expenses$530.06M
Operating Income$115.50M
Interest Expense$3.84M
Net Income$118.21M
EPS (Basic)$0.79
EPS (Diluted)$0.77
Shares Outstanding (Basic)149.71M
Shares Outstanding (Diluted)153.90M

Key Highlights

  • 1Total revenue for Q2 FY2019 increased by 8% year-over-year to $836.2 million.
  • 2Software Integrity segment revenue surged by 23% year-over-year, indicating strong growth in this area.
  • 3Operating income decreased by 9% to $115.5 million due to increased operating expenses, including restructuring charges.
  • 4The company adopted ASC 606, impacting revenue recognition and leading to a $11.8 million decrease in net income compared to the previous standard for the quarter.
  • 5Cash and cash equivalents stood at $631.2 million as of April 30, 2019.
  • 6Research and Development expenses increased by 15% year-over-year, reflecting continued investment in innovation.
  • 7The company maintained compliance with its financial covenants under its credit facilities.

Frequently Asked Questions